Clinical Trials Logo

Cataract clinical trials

View clinical trials related to Cataract.

Filter by:

NCT ID: NCT00876278 Withdrawn - Cataract Clinical Trials

Night Driving Pilot

Start date: June 2009
Phase: Phase 4
Study type: Interventional

Pilot study to evaluate usability of Mesotest II for assessment of night driving capacity of pseudo-phakic patients implanted with aspheric monofocal posterior chamber IOL *AT.Smart 46LC. Target Criterion: Measurement of contrast sensitivity and sensitivity to light under mesopic conditions (Mesotest II, Oculus).

NCT ID: NCT00825747 Withdrawn - Cataract Clinical Trials

Evaluation of Seelens AF, an Aspheric Intra-ocular Lens

Start date: January 2009
Phase: N/A
Study type: Interventional

Senile cataract is managed by cataract extraction and intra-ocular lens (IOL) implantation. The purpose of this study is to evaluate the safety and efficacy of the SeeLens AF, an acrylic hydrophilic aspheric IOL. This lens was designed to reduce vision aberrations and secondary cataract formation rate. Preoperative evaluation: Best corrected visual acuity, refraction, comprehensive slit lamp examination and biometry. Surgical procedure: Cataract surgery using a clear corneal incision (1.8mm to2.4mm), phacoemulsification and implantation of the SeeLens AF to the capsular bag. IOL implantation parameters will be evaluated by the surgeon. Postoperative follow up: Best corrected visual acuity, uncorrected visual acuity, refraction and comprehensive slit lamp examinations up to 3 months after surgery.

NCT ID: NCT00761488 Withdrawn - Cataract Clinical Trials

Recommendations for Monitoring Clinical Experience Following Implantation of the AcrySof® Toric

Start date: n/a
Phase: Phase 4
Study type: Interventional

To allow surgeons to obtain clinical experience on the postoperative uncorrected and best distance corrected visual acuities (UCVA and BDCVA) and corneal and refractive cylinder of the AcrySof Toric IOL.

NCT ID: NCT00760058 Withdrawn - Cataract Clinical Trials

Visual Outcome and Visual Quality After Bilateral Implantation of the AcrySof® IQ IOL Compared to MI60® and Tecnis® IOL

Start date: June 2008
Phase: Phase 4
Study type: Interventional

The objective of the study is to compare the visual outcomes of three aspheric monofocal intraocular lenses after cataract surgery - ACRYSOF® IQ, Tecnis® and Akreos® MI60.

NCT ID: NCT00708331 Withdrawn - Cataract Extraction Clinical Trials

Hydrophilic Acrylic Intraocular Lens

Start date: August 2002
Phase: N/A
Study type: Interventional

The purpose of this study is to evaluate the safety and efficacy of Hydrophilic Acrylic Intraocular Lens after cataract surgery

NCT ID: NCT00565630 Withdrawn - Cataract Clinical Trials

Using Device Delivering Ophthalmic Solution in a Spray Form Instead of Eye Drops

Start date: January 2008
Phase: N/A
Study type: Interventional

The purpose of the study is to confirm that Vigamox reaches similar aqueous concentration when administered as the commercially available eye drops or as a spray delivered from a proprietary device.

NCT ID: NCT00487838 Withdrawn - Clinical trials for Age-Related Macular Degeneration

Effects of Sun Filters on Age-related Macular Degeneration in People With Lens Implants

Start date: June 14, 2007
Phase: N/A
Study type: Observational

This study will test a new method for preventing worsening of age-related macular degeneration (AMD) and for developing imaging methods to follow the very earliest microscopic changes in the disease. The macula is the part of the retina in the back of the eye that determines central vision. AMD can impair central vision, affecting a person's ability to read, drive, and carry out daily activities. Some studies suggest that cumulative exposure to sunlight increases the risk for progression of AMD to the late stage that is often characterized by poor central vision. This study will determine if wearing glasses with a yellow filter over one eye and a red-violet filter over the other eye when outdoors will decrease the rate of change of early-stage AMD in one or both eyes. Patients early-stage AMD who have had cataract surgery in both eyes with implanted lenses may be eligible for this study. Participants undergo the following procedures: - Wear the filter glasses when outdoors between 10:00 a.m. and 4:00 p.m. - Record the time of day and light environment when they use the glasses. - Have an eye examination, pictures of the retina, and a medical history taken at the beginning of the study and at set intervals during the study. The study lasts at least 12 months and may be extended for a longer period of time....

NCT ID: NCT00466908 Withdrawn - Cataract Extraction Clinical Trials

Accuracy of the Pentacam and IOL Master to Calculate the Effective Corneal Power After Corneal Refractive Surgery

Start date: March 2007
Phase:
Study type: Observational

The purpose of this study is to determine the accuracy of the Pentacam and IOL Master to calculate the effective corneal power (keratometry, corneal curvature) in patients who have undergone both corneal refractive surgery and lens extraction with intraocular lens implantation.

NCT ID: NCT00366613 Withdrawn - Cataract Extraction Clinical Trials

Clinical Evaluation of the Use of Sealed Capsule Irrigation With Sodium Chloride During Pediatric Cataract Surgery and IOL Implantation

Start date: July 2005
Phase: Phase 4
Study type: Interventional

This study involves using both a device that seals the capsular bag (where the lens is located) allowing safer irrigation of the capsular bag and sodium chloride to irrigate the capsular bag during cataract surgery on children. The purpose of this study is to determine if the use of the device, Perfect Capsule, along with sodium chloride reduces the development of posterior capsule opacification (PCO), a possible complication of cataract surgery. PCO is the clouding of the rear portion of the natural membrane or capsule that holds the artificial lens. It requires additional procedures to correct the problem. Sodium chloride is not usually used during cataract surgery. It will be used to irrigate the capsular bag and remove any residual cells that contribute to the development of PCO. Perfect Capsule will prevent the sodium chloride from touching other parts of the eye. The goal of this study is to determine if irrigation with sodium chloride will lower the incidence of PCO after cataract surgery.

NCT ID: NCT00335231 Withdrawn - Endophthalmitis Clinical Trials

Preoperative Topical Gatifloxacin on Anterior Chamber Cultures After Cataract Surgery

Start date: June 2006
Phase: N/A
Study type: Interventional

Postoperative endophthalmitis, a possible severe complication of cataract surgery, is an infection of the anterior chamber of the eye caused by bacterial contamination and colonization through surgical incisions. Bacteria are thought to originate mainly from the patient's skin and studies show that bacteria are commonly found in the anterior chamber following surgery. However, innate immune defences are usually able to control and eliminate bacterial growth before postoperative endophthalmitis occurs. Also, due to the low incidence of postoperative endophthalmitis, it is difficult to accurately evaluate preventative methods. This study will examine the efficacy of topical preoperative administration of gatifloxacin (a new fourth generation fluoroquinolone antibiotic) on reduction of bacterial contamination of the anterior chamber following cataract surgery. If the antibiotic is shown to lower bacteria count in cultures from anterior chamber fluid, it has the potential to lower the incidence of postoperative endophthalmitis. Patients undergoing cataract surgery will be notified and asked to participate in the study by the physician in advance of the surgery, provided they do not possess any exclusion criteria. The participants will be randomly split into two groups; one group will receive topical application of gatifloxacin prior to surgery, while the other group will receive no eye drops. During surgery, a small sample of anterior chamber fluid will be removed from the eye and cultured in both broth and enrichment media for all subjects. Bacterial growth, i.e., colony forming units (CFUs), will be used as an indicator of the bacterial contamination of the fluid.